Abstract
Undescended testes (cryptorchidism) represent the most common malformation in boys: retractile, inguinal, or abdominal testes are present in 1–5% of male neonates born at term. During the first 9 months of life, some of these testes descend spontaneously as they continue to mature, reducing the prevalence of cryptorchidism at age 9 months to 1–1.5% without treatment. Among other factors, fetal androgen deficiency or insufficient androgen action may be at the origin of impaired testicular descent into the scrotum. Previously undescended testes may lead to fertility limitations in men and may cause endocrine testicular dysfunction. If treated too late, the undescended testis carries an increased risk of malignant transformation. The high-ambient temperature of testes located in an extra-scrotal location is held responsible for both increased apoptosis of the germ cells and for the increased risk of testicular germ cell tumors. Persistent undescended testes therefore require treatment. According to current guidelines, hormonal or surgical correction should be completed by the boy’s first birthday. Early correction reduces the risk of testicular tumor development and may have beneficial effects on testicular endocrine and spermatogenic function in adolescence and adulthood.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Barthold JS, Manson J, Regan V, Si X, Hassink SG, Coughlin MT, Lee PA (2004) Reproductive hormone levels in infants with cryptorchidism during postnatal activation of the pituitary-testicular axis. J Urol 172:1736–1741
Berkowitz GS, Lapinski RH, Dolgin SE, Gazella JG, Bodian CA, Holzman IR (1993) Prevalence and natural history of cryptorchidism. Pediatrics 92:44–49
Bougnères P, François M, Pantalone L, Rodrigue D, Bouvattier C, Demesteere E, Roger D, Lahlou N (2008) Effects of an early postnatal treatment of hypogonadotropic hypogonadism with a continuous subcutaneous infusion of recombinant follicle-stimulating hormone and luteinizing hormone. J Clin Endocrinol Metab 93:2202–2205
Bradshaw CJ, Corbet-Burcher G, Hitchcock R (2014) Age at orchidopexy in the UK: has new evidence changed practice? J Pediatr Urol 10:758–762
Bukowski TP, Wacksman J, Billmire DA, Lewis AG, Sheldon CA (1995) Testicular autotransplantation: a 17-year review of an effective approach to the management of the intraabdominal testis. J Urol 154:558–561
Clarnette D, Rowe D, Hasthorpe S, Hutson JM (1997) Incomplete disappearance of the processus vaginalis as a cause of ascending testis. J Urol 157:1889–1891
Cortes D, Thorup J, Visfeldt J (2000) Hormonal treatment may harm the germ cells in 1 to 3-year-old boys with cryptorchidism. J Urol 163:1290–1292
Cortes D, Thorup JM, Visfeldt J (2001) Cryptorchidism: aspects of fertility and neoplasms. A study including data of 1,335 consecutive boys who underwent testicular biopsy simultaneously with surgery for cryptorchidism. Horm Res 55:21–27
Cortes D, Clasen-Linde E, Hutson JM, Li R, Thorup J (2016) The Sertoli cell hormones inhibin-B and anti Müllerian hormone have different patterns of secretion in prepubertal cryptorchid boys. J Pediatr Surg 51:475–480
D’Agostino S, Zen F, Ioverno E, Pesce C, Belloli G (1996) Cryptorchidism and fertility: evaluation in adult age. Pediatr Med Chir 18:37–40
Damgaard IN, Jensen TK, Nordic Cryptorchidism Study Group, Petersen JH, Skakkebaek NE, Toppari J, Main KM (2008) Risk factors for congenital cryptorchidism in a prospective birth cohort study. PLoS One 3:e3051
Docimo SG (1995) The results of surgical therapy for cryptorchidism: a literature review and analysis. J Urol 154:1148–1152
Dunkel L, Taskinen S, Hovatta O, Tilly JL, Wikström S (1997) Germ cell apoptosis after treatment of cryptorchidism with human chorionic gonadotropin is associated with impaired reproductive function in the adult. J Clin Invest 100:2341–2346
Giwercman A, Grindsted J, Hansen B (1987) Testicular cancer risk in boys with maldescended testis: a cohort study. J Urol 138:1214–1216
Gotoh M, Miyake K, Mitsuya H (1984) Leydig cell hyperplasia in cryptorchid patients: quantitative evaluation of Leydig cells in undescended and contralateral scrotal testes. Urol Res 12:159–164
Hadziselimovic F, Herzog B (1997) Treatment with a luteinizing hormone-releasing hormone analogue after successful orchiopexy markedly improves the chance of fertility later in life. J Urol 158:1193–1195
Hadziselimovic F, Herzog B (2001) The importance of both an early orchidopexy and germ cell maturation for fertility. Lancet 358:1156–1157
Hadziselimovic F, Thommen L, Girard J, Herzog B (1986) The significance of postnatal gonadotropin surge for testicular development in normal and cryptorchid testes. J Urol 136:274–276
Han WK, Kim JH, Hong CH, Han SW (2004) Structural evidence against hormonal therapy for cryptorchid testis: abnormal gubernacular attachment. J Urol 171:2427–2429
Heiskanen P, Billig H, Toppari J, Kaleva M, Arsalo A, Rapola J, Dunkel L (1996) Apoptotic cell death in the normal and cryptorchid human testis: the effect of human chorionic gonadotropin on testicular cell survival. Pediatr Res 40:351–356
Henna MR, Del Nero RG, Smapaio CZ, Atalah AN, Schettini ST, Castro AA, Soares BG (2004) Hormonal cryptorchidism therapy: systematic review with metanalysis of randomized clinical trials. Pediatr Surg Int 20:357–359
Hensel KO, Caspers T, Jenke AC, Schuler E, Wirth S (2015) Operative management of cryptorchidism: guidelines and reality - a 10-year observational analysis of 3587 cases. BMC Pediatr 15:116
Hiort O, Wünsch L, Holterhus PM (2005) Differenzialdiagnostische Überlegungen beim Hodenhochstand. Monatsschrift Kinderheilkd; pp 430–435
Hoorweg-Nijman JJG, Havers HM, Delemarre-van de Waal HA (1994) Effect of human chorionic gonadotrophin (hCG) /follicle-stimulating hormone treatment versus hCG treatment alone on testicular descent: a double-blind placebo-controlled study. Eur J Endocrinol 130:60–64
Huff DS, Fenig DM, Canning DA, Carr MG, Zderic SA, Snyder HM (2001) Abnormal germ cell development in cryptorchidism. Horm Res 55:11–17
Hughes IA, Acerini CL (2008) Factors controlling testis descent. Eur J Endocrinol 159(Suppl 1):75–82
Hutson JM (1986) Testicular feminization: a model for testicular descent in mice and men. J Pediatr Surg 21:195–198
Hutson JM, Nation T, Bilic A, Southwell BR (2009) The role for the gubernaculum in the descent and undescent of the testis. Ther Adv Urol 1:115–121
Hutson JM, Southwell BR, Li R, Lie G, Ismail K, Harisis G, Chen N (2013) The regulation of testicular descent and the effects of cryptorchidism. Endocr Rev 34:725–752
Imperato-McGinley J, Guerrero L, Gautier T, Peterson RE (1974) Steroid 5-α-reductase deficiency in man: an inherited form of male pseudohermaphroditism. Science 186:1213–1215
Job JC, Toublanc JE, Chaussain JL, Gendrel D, Roger M, Canlorbe P (1987) The pituitary-gonadal axis in cryptorchid infants and children. Eur J Pediatr 146:2–5
Job JC, Toublanc JE, Chaussain JL, Gendrel D, Garnier P, Roger M (1988) Endocrine and immunological findings in cryptorchid infants. Horm Res 30:167–172
Kaleva M, Arsalo A, Louhimo I, Rapola J, Perheentupa J, Henriksen K, Toppari J (1996) Treatment with human chorionic gonadotrophin for cryptorchidism: clinical and histological effects. Int J Androl 19:293–298
Kaplan LM, Koyle MA, Kaplan GW, Farrer JH, Rajfer J (1986) Association between abdominal wall defects and cryptorchidism. J Urol 136:645–647
Kohva E, Huopio H, Hietamäki J, Hero M, Miettinen PJ, Raivio T (2019) Treatment of gonadotropin deficiency during the first year of life: long-term observation and outcome in five boys. Hum Reprod 34:863–871
Kollin C, Karpe B, Hesser U, Granholm T, Ritzen EM (2007) Surgical treatment of unilaterally undescended testes: testicular growth after randomization to orchiopexy at age 9 months or 3 years. J Urol 178:1589–1593
Kollin C, Stukenborg JB, Nurmio M, Sundqvist E, Gustafsson T, Söder O, Toppari J, Nordenskjöld A, Ritzén EM (2012) Boys with undescended testes: endocrine, volumetric and morphometric studies on testicular function before and after orchidopexy at nine months or three years of age. J Clin Endocrinol Metab 97:4588–4595
Lambert AS, Bougneres P (2016) Growth and descent of the testes in infants with hypogonadotropic hypogonadism receiving subcutaneous gonadotropin infusion. Int J Pediatr Endocrinol 2016:13
Lee PA (2005) Fertility in cryptorchidism: epidemiology and other outcome studies. Urology 66:427–431
Lee PA, Coughlin MT (2001) Fertility after bilateral cryptorchidism. Evaluation by paternity, hormone, and semen data. Horm Res 55:28–32
Li T, Gao L, Chen P, Bu S, Cao D, Yang L, Wei Q (2016) A systematic review and meta-analysis of comparative studies assessing the efficacy of luteinizing hormone-releasing hormone therapy for children with cryptorchidism. Int Urol Nephrol 48:635–644
Mathers MJ, Sperling H, Rübben H, Roth S (2009) The undescended testis: diagnosis, treatment and long-term consequences. Dtsch Arztebl Int 106:527–532
McEachern R, Houle AM, Garel L, Van Vliet G (2004) Lost and found testes: the importance of the hCG stimulation test and other testicular markers to confirm a surgical declaration of anorchia. Horm Res 62:124–128
Miller M, Coughlin M, Lee P (2001) Fertility after unilateral cryptorchidism: Paternity, time to conception, pretreatment testicular location and sex hormone and sperm parameters. Horm Res 55:249–253
Muncey W, Dutta R, Terlecki RP, Woo LL, Scarberry K (2021) Fertility potential in adult men treated for uncorrected bilateral cryptorchidism: a Systematic literature review and analysis of case reports. Andrology. 9(3):781–791
Papadimitriou DT, Chrysis D, Nyktari G, Zoupanos G, Liakou E, Papadimitriou A, Mastorakos G (2019) Replacement of male mini-puberty. J Endocr Soc 3:1275–1282
Pettersson A, Richiardi L, Nordenskjold A, Kaijser M, Akre O (2007) Age at surgery for undescended testis and risk of testicular cancer. N Engl J Med 356:1835–1841
Pierik FH, Deddens JA, Burdorf A, de Muinck Keizer-Schrama SM, Jong FH, Weber RF (2009) The hypothalamus-pituitary-testis axis in boys during the first six months of life: a comparison of cryptorchidism and hypospadias cases with controls. Int J Androl 32:453–461
Pitteloud N, Hayes FJ, Dwyer A, Boepple PA, Lee H, Crowley WF Jr (2002) Predictors of outcome of long-term GnRH therapy in men with idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab 87:4128–4136
Pyörälä S, Huttunen N-P, Uhari M (1995) A review and meta-analysis of hormonal treatment of cryptorchidism. J Clin Endocrinol Metab 80:2795–2799
Radmayr C, Dogan HS, Hoebeke P, Kocvara R, Nijman R, Silay S, Stein R, Undre S, Tekgul S (2017) Management of undescended testes: European Association of Urology/European Society for Paediatric Urology Guidelines. Urology 110:213–215
Ritzén EM, Bergh A, Bjerknes R, Christiansen P, Cortes D, Haugen SE, Jörgensen N, Kollin C, Lindahl S, Läckgren G, Main KM, Nordenskjöld A, Rajpert-De Meyts E, Söder O, Taskinen S, Thorsson A, Thorup J, Toppari J, Virtanen H (2007) Nordic consensus on treatment of undescended testes. Acta Paediatr 96:638–643
Rohayem J, Sinthofen N, Nieschlag E, Kliesch S, Zitzmann M (2016) Causes of hypogonadotropic hypogonadism predict response to gonadotropin substitution in adults. Andrology 4:87–94
Rohayem J, Luberto A, Nieschlag E, Zitzmann M, Kliesch S (2017) Delayed treatment of undescended testes may promote hypogonadism and infertility. Endocrine 55:914–924
Sadov S, Koskenniemi JJ, Virtanen HE, Perheentupa A, Petersen JH, Skakkebaek NE, Main KM, Toppari J (2016) Testicular growth during puberty in boys with and without a history of congenital cryptorchidism. J Clin Endocrinol Metab 101:2570–2577
Schwentner C, Oswald J, Kreczy A, Lunacek A, Bartsch G, Deibl M, Radmayr C (2005) Neoadjuvant gonadotropin-releasing hormone therapy before surgery may improve the fertility index in undescended testes: a prospective randomized trial. J Urol 173:974–977
Stephens FD (1988) Fowler-Stephens orchiopexy. Semin Urol 2:103–106
Suomi AM, Main KM, Kaleva M, Schmidt IM, Chellakooty M, Virtanen HE, Boisen KA, Damgaard IN, Kai CM, Skakkebaek NE, Toppari J (2006) Hormonal changes in 3-month-old cryptorchid boys. J Clin Endocrinol Metab 91:953–958
Taran I, Elder JS (2006) Results of orchiopexy for the undescended testis. World J Urol 24:231–239
Tasian GE, Hittelman AB, Kim GE, DiSandro MJ, Baskin LS (2009) Age at orchiopexy and testis palpability predict germ and Leydig cell loss: clinical predictors of adverse histological features of cryptorchidism. J Urol 182:704–709
Toppari J, Kaleva M (1999) Maldescensus testis. Horm Res 51:261–269
Varela-Cives R, Mendez-Gallart R, Estevez-Martinez E, Rodriguez-Barca P, Bautista-Casasnovas A, Pombo-Arias M, Tojo-Sierra R (2015) A cross-sectional study of cryptorchidism in children: testicular volume and hormonal function at 18 years of age. Int Braz J Urol 41:57–66
Vloeberghs V, Verheyen G, Haentjens P, Goossens A, Polyzos NP, Tournaye H (2015) How successful is TESE-ICSI in couples with non-obstructive azoospermia? Hum Reprod 30:1790–1796
Wei Y, Wang Y, Tang X, Liu B, Shen L, Long C, Lin T, He D, Wu S, Wei G (2018) Efficacy and safety of human chorionic gonadotropin for treatment of cryptorchidism: A meta-analysis of randomised controlled trials. J Paediatr Child Health 54:900–906
Yadav SK, Pandey A, Kumar L, Devi A, Kushwaha B, Vishvkarma R, Maikhuri JP, Rajender S, Gupta G (2018) The thermo-sensitive gene expression signatures of spermatogenesis. Reprod Biol Endocrinol 16:56
Yavetz H, Harash B, Paz G, Yogev L, Jaffa AJ, Lessing JB, Homonnai ZT (1992) Cryptorchidism: incidence and sperm quality in infertile men. Andrologia 24:293–297
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Rohayem, J., Nieschlag, E. (2023). Undescended Testes. In: Nieschlag, E., Behre, H.M., Kliesch, S., Nieschlag, S. (eds) Andrology. Springer, Cham. https://doi.org/10.1007/978-3-031-31574-9_17
Download citation
DOI: https://doi.org/10.1007/978-3-031-31574-9_17
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-31573-2
Online ISBN: 978-3-031-31574-9
eBook Packages: MedicineMedicine (R0)